pI: 6.1995 |
Length (AA): 550 |
MW (Da): 60345 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
24 | 296 | 4aez (A) | 125 | 398 | 24.00 | 0.000051 | 1 | 0.606864 | 0.68 |
95 | 222 | 1nr0 (A) | 7 | 135 | 16.00 | 0 | 0.4 | 0.396927 | 0.04 |
101 | 207 | 4ery (A) | 50 | 146 | 31.00 | 0.0001 | 0.98 | 0.532045 | -0.41 |
137 | 179 | 4a11 (B) | 36 | 77 | 43.00 | 0.31 | 0.45 | 0.466682 | 0.05 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128392)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G64630 | chromatin assembly factor 1 subunit FAS2 |
Babesia bovis | BBOV_IV007050 | chromatin assembly factor 1 subunit B, putative |
Brugia malayi | Bm1_36390 | Chromatin assembly factor 1 subunit B |
Candida albicans | CaO19.6670 | subunit of chromatin assembly factor 1 |
Caenorhabditis elegans | CELE_Y71G12B.1 | Protein CHAF-2, isoform A |
Cryptosporidium hominis | Chro.70070 | hypothetical protein |
Cryptosporidium parvum | cgd7_560 | hypothetical protein |
Dictyostelium discoideum | DDB_G0277941 | WD40 repeat-containing protein |
Dictyostelium discoideum | DDB_G0269800 | hypothetical protein |
Drosophila melanogaster | Dmel_CG12892 | CG12892 gene product from transcript CG12892-RA |
Echinococcus granulosus | EgrG_000461100 | chromatin assembly factor 1 subunit b |
Echinococcus multilocularis | EmuJ_000461100 | chromatin assembly factor 1 subunit b |
Homo sapiens | 8208 | chromatin assembly factor 1, subunit B (p60) |
Leishmania braziliensis | LbrM.35.2710 | chromatin assembly factor 1 subunit b-like protein |
Leishmania donovani | LdBPK_362630.1 | chromatin assembly factor 1 subunit b-like protein |
Leishmania infantum | LinJ.36.2630 | chromatin assembly factor 1 subunit b-like protein |
Leishmania major | LmjF.36.2500 | chromatin assembly factor 1 subunit b-like protein |
Leishmania mexicana | LmxM.36.2500 | chromatin assembly factor 1 subunit b-like protein |
Loa Loa (eye worm) | LOAG_04232 | chromatin assembly factor 1 subunit B |
Mus musculus | ENSMUSG00000022945 | chromatin assembly factor 1, subunit B (p60) |
Neospora caninum | NCLIV_031600 | hypothetical protein |
Oryza sativa | 4344464 | Os08g0108200 |
Plasmodium berghei | PBANKA_1101600 | chromosome assembly factor 1, putative |
Plasmodium falciparum | PF3D7_0501800 | chromosome assembly factor 1 |
Plasmodium knowlesi | PKNH_1032100 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_097595 | hypothetical protein, conserved |
Plasmodium yoelii | PY03920 | Arabidopsis thaliana At5g64630/MUB3_15 |
Saccharomyces cerevisiae | YML102W | Cac2p |
Schistosoma japonicum | Sjp_0120800 | Chromatin assembly factor 1 subunit B, putative |
Schistosoma japonicum | Sjp_0103730 | ko:K10751 chromatin assembly factor 1 subunit B, putative |
Schistosoma mansoni | Smp_153610 | chromatin assembly factor I P60 subunit |
Schmidtea mediterranea | mk4.000650.07 | Chromatin assembly factor 1 subunit B |
Trypanosoma brucei gambiense | Tbg972.10.8600 | chromatin assembly factor 1 subunit B, putative |
Trypanosoma brucei | Tb927.10.7050 | chromatin assembly factor 1 subunit B, putative |
Trypanosoma congolense | TcIL3000_10_6050 | chromatin assembly factor 1 subunit B, putative |
Trypanosoma cruzi | TcCLB.510181.60 | chromatin assembly factor 1 subunit B, putative |
Trypanosoma cruzi | TcCLB.503431.100 | chromatin assembly factor 1 subunit B, putative |
Toxoplasma gondii | TGME49_231280 | WD domain, G-beta repeat-containing protein |
Theileria parva | TP03_0203 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7050 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7050 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7050 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.7050 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y71G12B.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y71G12B.1 | Caenorhabditis elegans | sterile | wormbase |
TGME49_231280 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.